Richard Elliott
- Molecular Biology top 5%
- Oncology top 2%
- Pulmonary and Respiratory Medicine top 5%
- Cancer Research top 10%
- Organic Chemistry top 10%
- Co-authors
- Christopher J. LordAlan AshworthNicholas C. TurnerIlirjana BajramiSydonia RayterAndrew TuttElizabeth IornsJulia Boshuizen
- Topics
- PARP inhibition in cancer therapy (7 papers)DNA Repair Mechanisms (6 papers)Cell Image Analysis Techniques (6 papers)
- Partner nations
- United KingdomUnited StatesAustralia
In The Last Decade
Richard Elliott
46 papers receiving 2.4k citations
Hit Papers
Peers
Comparison fields: 5 of 121
- Molecular Biology 1.4k
- Oncology 1.2k
- Pulmonary and Respiratory Medicine 555
- Cancer Research 303
- Organic Chemistry 209
Countries citing papers authored by Richard Elliott
This map shows the geographic impact of Richard Elliott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Elliott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Elliott more than expected).
Fields of papers citing papers by Richard Elliott
This network shows the impact of papers produced by Richard Elliott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Elliott. The network helps show where Richard Elliott may publish in the future.
Co-authorship network of co-authors of Richard Elliott
This figure shows the co-authorship network connecting the top 25 collaborators of Richard Elliott. A scholar is included among the top collaborators of Richard Elliott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Elliott. Richard Elliott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 5 | |
| 3 | 2 | |
| 4 | 67 | |
| 5 | 4 | |
| 6 | 6 | |
| 7 | 4 | |
| 8 | 16 | |
| 9 | 39 | |
| 10 | 47 | |
| 11 | Early Adaptation and Acquired Resistance to CDK4/6 Inhibition in Estrogen Receptor–Positive Breast Cancerbreakdown → | 511 |
| 12 | 12 | |
| 13 | 48 | |
| 14 | 378 | |
| 15 | 27 | |
| 16 | 22 | |
| 17 | 66 | |
| 18 | 3 | |
| 19 | 69 | |
| 20 | 45 |
About Richard Elliott
Richard Elliott is a scholar working on Biophysics, Toxicology and Oncology, having authored 47 papers that have together received 2.4k indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (7 papers), DNA Repair Mechanisms (6 papers) and Cell Image Analysis Techniques (6 papers). The work is most often cited by research in Oncology (1.2k citations), Cancer Research (303 citations) and Molecular Biology (1.4k citations). Richard Elliott has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Christopher J. Lord, Alan Ashworth, Nicholas C. Turner, Ilirjana Bajrami, Sydonia Rayter, Andrew Tutt, Elizabeth Iorns, Julia Boshuizen, Ying Feng and Yuqiao Shen. Their work appears in journals such as Physical Review Letters, Advanced Materials and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.